This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

14C-glycocholate breath test

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

14C-labelled glycocholate is administered orally. In the presence of bacterial overgrowth in the small bowel, extensive deconjugation of 14C-glycine occurs. The labelled glycine is rapidly absorbed and metabolised to 14C-carbon dioxide which is detected in the breath.

Deconjugation may also occur if the 14C-glycocholate reaches the colon. Bile salts are usually reabsorbed in the terminal ileum and such 'false' positive results may occur in patients with abnormal ileal function e.g. in Crohn's disease.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.